Cargando…
Individual approach for treatment of primary intestinal lymphangiectasia in children: single-center experience and review of the literature
BACKGROUND: Intestinal lymphangiectasia is a rare disease. Thus, prospective studies are impossible, and therapy is still controversial. Several medicines are suggested for treatment but there are no existing indications for drug choice and treatment guidelines. We aimed to introduce the action mech...
Autores principales: | Kwon, Yiyoung, Kim, Eun Sil, Choe, Yon Ho, Kim, Mi Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789338/ https://www.ncbi.nlm.nih.gov/pubmed/33407260 http://dx.doi.org/10.1186/s12887-020-02447-5 |
Ejemplares similares
-
Therapeutic Lymphatic Embolization in Pediatric Primary Intestinal Lymphangiectasia
por: Kwon, Yiyoung, et al.
Publicado: (2021) -
The Update of Treatment for Primary Intestinal Lymphangiectasia
por: Kwon, Yiyoung, et al.
Publicado: (2021) -
Upper gastrointestinal tract involvement is more prevalent in Korean patients with pediatric Crohn’s disease than in European patients
por: Kim, Eun Sil, et al.
Publicado: (2020) -
COVID-19-related school closing aggravate obesity and glucose intolerance in pediatric patients with obesity
por: Kim, Eun Sil, et al.
Publicado: (2021) -
Albumin-to-Globulin Ratio at 1 Year after Anti-Tumor Necrosis Factor α Therapy Can Serve as a Prognostic Biomarker in Pediatric Crohn’s Disease Patients
por: Kim, Eun Sil, et al.
Publicado: (2022)